Cytosorbents CorporationCTSONASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.65% |
| Q3 2025 | -1.37% |
| Q2 2025 | 10.20% |
| Q1 2025 | -4.62% |
| Q4 2024 | 6.24% |
| Q3 2024 | -2.59% |
| Q2 2024 | -1.64% |
| Q1 2024 | 22.33% |
| Q4 2023 | -5.23% |
| Q3 2023 | -17.69% |
| Q2 2023 | -0.30% |
| Q1 2023 | 0.63% |
| Q4 2022 | 45.30% |
| Q3 2022 | -23.93% |
| Q2 2022 | 7.21% |
| Q1 2022 | -26.50% |
| Q4 2021 | 21.12% |
| Q3 2021 | -21.68% |
| Q2 2021 | 12.05% |
| Q1 2021 | -15.16% |
| Q4 2020 | 16.69% |
| Q3 2020 | 7.62% |
| Q2 2020 | 16.73% |
| Q1 2020 | 23.39% |
| Q4 2019 | 15.40% |
| Q3 2019 | -2.09% |
| Q2 2019 | 27.81% |
| Q1 2019 | -16.34% |
| Q4 2018 | 7.21% |
| Q3 2018 | -2.73% |
| Q2 2018 | 18.34% |
| Q1 2018 | 3.19% |
| Q4 2017 | 24.56% |
| Q3 2017 | 13.42% |
| Q2 2017 | 17.14% |
| Q1 2017 | -0.65% |
| Q4 2016 | 21.93% |
| Q3 2016 | 15.65% |
| Q2 2016 | 16.03% |
| Q1 2016 | 6.75% |